Specified Prescription Medicines for Designated Registered Nurse Prescribers
This notice revokes and replaces the notice published in the New Zealand Gazette, 1 September 2016, Issue No. 77, Notice No. 2016-go5037.
Pursuant to section 105(5A) of the Medicines Act 1981, I, Dr Stewart Jessamine, Director, Protection, Regulation and Assurance, Ministry of Health, acting under delegated authority, hereby declare the following prescription medicines are specified prescription medicines for the purposes of the Medicines (Designated Prescriber – Registered Nurses) Regulations 2016:
Every reference to a medicine in this notice applies whether the medicine is synthetic in origin or is from biological or mineral sources.
Unless specific reference is made otherwise, every reference applies also to medicines that are:
Unless specific reference is made otherwise, every reference to a medicine applies:
Where any reference is modified by a statement of the strength of the medicine, the strength is calculated using the free acid, base, alcohol or element unless specifically stated otherwise.
Aciclovir
Adapalene
Adrenaline
Alfacalcidol
Allopurinol
Amethocaine; ophthalmic use only
Amitriptyline
Amlodipine
Amoxycillin
Atenolol
Atorvastatin
Atovaquone
Atropine; ophthalmic use only
Azithromycin
Beclomethasone
Bendrofluazide
Benzathine penicillin
Benzylpenicillin
Betamethasone
Bezafibrate
Bimatoprost
Bisoprolol
Brimonidine
Brinzolamide
Budesonide
Bumetanide
Buspirone
Calcipotriol
Candesartan
Carvedilol
Cefaclor
Cefazolin
Ceftriaxone
Cefuroxime
Celiprolol
Cephalexin
Cetirizine
Chloramphenicol
Cilazapril
Cinchocaine
Citalopram
Clarithromycin
Clavulanic acid
Clioquinol
Clobetasol
Clonidine
Colecalciferol
Colestipol
Colestyramine
Cyclopentolate
Dalteparin
Danthron
Desogestrel
Dexamethasone
Diclofenac
Digoxin
Diltiazem
Dipyridamole
Disopyramide
Disulfiram
Domperidone
Dorzolamide
Doxazosin
Doxycycline
Drospirenone
Enalapril
Enoxaparin
Epoetins
Erythromycin
Escitalopram
Ethinylestradiol
Etonogestrel
Ezetimibe
Famciclovir
Felodipine
Flucloxacillin
Flumethasone
Fluocortolone
Fluorescein
Fluorometholone
Fluoxetine
Fluticasone
Fluvoxamine
Formoterol
Framycetin
Furosemide
Fusidic acid
Gabapentin
Ganciclovir
Gliclazide
Glipizide
Glyceryl trinitrate; for transdermal use
Gramicidin
Haloperidol
Heparins
Hydrochlorothiazide
Hydrocortisone; for aural use
Hyoscine
Ibuprofen
Immunoglobulins
Indapamide
Insulins
Ipratropium
Isosorbide mononitrate
Ivermectin
Ketoprofen
Labetalol
Lansoprazole
Latanoprost
Levonorgestrel
Lignocaine
Lisinopril
Loperamide
Losartan
Medroxyprogesterone
Mefenamic acid
Mefloquine
Melatonin
Metformin
Methoxyflurane
Methyldopa
Methylprednisolone
Metoclopramide
Metoprolol
Metronidazole
Misoprostol
Mometasone
Montelukast
Mupirocin
Nadolol
Naloxone
Naltrexone
Naproxen
Natamycin
Nedocromil
Nefopam
Neomycin
Nitrofurantoin
Norethisterone
Norfloxacin
Nortriptyline
Nystatin
Omeprazole
Ondansetron
Ornidazole
Orphenadrine
Oseltamivir
Oxybuprocaine
Oxybutynin
Pantoprazole
Paroxetine
Perindopril
Phenoxymethylpenicillin
Pilocarpine
Pizotifen
Podophyllotoxin
Polymyxin
Pravastatin
Prednisolone
Prednisone
Probenecid
Procaine penicillin
Prochlorperazine
Proguanil
Promethazine
Proxymetacaine
Quinapril
Ranitidine
Rifampicin
Rizatriptan
Roxithromycin
Salbutamol
Salmeterol
Sertraline
Simvastatin
Sodium cromoglycate; for inhalation use
Solifenacin
Spironolactone
Sulfamethoxazole
Sulfasalazine
Sulindac
Sumatriptan
Tenoxicam
Terazosin
Terbutaline
Tiaprofenic acid
Timolol
Tiotropium
Tobramycin
Tramadol
Trandolapril
Tranexamic acid
Travoprost
Tretinoin
Triamcinolone
Trimethoprim
Tropicamide
Vaccines
Valaciclovir
Valproic acid
Warfarin
Zopiclone
Dated this 5th day of September 2016.
Dr STEWART JESSAMINE, Director, Protection, Regulation and Assurance, Ministry of Health.